Healthcare Triangle
HCTI
0 hedge funds and large institutions have $76.1K invested in Healthcare Triangle in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
94% less capital invested
Capital invested by funds: $1.22M → $76.1K (-$1.15M)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23K |
| 3 |
Millennium Management
New York
|
-$4K |
HCTI Hedge Fund Activity: Q4 2022 in Review
0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Healthcare Triangle (HCTI) for Q4 2022, worth a combined $76.1K — down 94% from $1.22M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HCTI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Armistice Capital, exiting entirely with an estimated $1.14M sold.
- 0 institutional investors held Healthcare Triangle (HCTI) as of Q4 2022, down from 1 in Q3 2022.
- Funds reported $76.1K of Healthcare Triangle stock for Q4 2022, down 94% quarter-over-quarter.
- 0 funds opened new Healthcare Triangle positions in Q4 2022 and 1 closed out, a net change of -1 holder.
- The largest Healthcare Triangle seller in Q4 2022 was Armistice Capital, an estimated $1.14M sold.
Based on aggregated 13F filings for Q4 2022.